Improving brain resilience to Alzheimer's disease
Promoting Brain Resilience to Alzheimer's Neuropathology
This study is looking at ways to help the brain stay strong against Alzheimer's disease by exploring how tiny particles from brain cells might protect important connections in the brain, with the hope of finding new treatments that could help improve thinking and memory for people with Alzheimer's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10830300 on NIH RePORTER |
What this research studies
This research investigates how to enhance the brain's ability to resist damage caused by Alzheimer's disease, particularly focusing on the early pathological changes that occur. The approach involves studying the role of exosomes released by neural stem cells, which may help protect synapses from the harmful effects of amyloid and tau proteins. By understanding these mechanisms, the research aims to develop new therapeutic strategies that could improve cognitive function in patients with Alzheimer's. Patients may benefit from insights into how their brain's resilience can be supported as they age.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults who are experiencing early signs of cognitive decline or have a family history of Alzheimer's disease.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help preserve cognitive function in individuals at risk for or suffering from Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using neural stem cell-derived exosomes to enhance synaptic resilience, indicating a potential for success in this novel approach.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Taglialatela, Giulio — University of Texas Med Br Galveston
- Study coordinator: Taglialatela, Giulio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.